H1N1: Can a pandemic cycle be broken?

Science Translational Medicine

Volumn 2, Issue 24, 2010, Pages

  Settembre, Ethan C ^a,b   Dormitzer, Philip R ^a,b   Rappuoli, Rino ^a,b  

^a Novartis Vaccines and Diagnostic   (United States)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ANTIGENICITY; CELLULAR IMMUNITY; CROSS REACTION; DRUG DESIGN; GLYCOSYLATION; HUMAN; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MOLECULAR EVOLUTION; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SHORT SURVEY; VACCINE PRODUCTION; VIRUS ENTRY; VIRUS STRAIN; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE OUTBREAKS; IMMUNOLOGY; INFLUENZA, HUMAN; PHYSIOLOGY; VACCINATION; VIROLOGY;

DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; GLYCOSYLATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, MOLECULAR; VACCINATION;

EID: 77953009109     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000948     Document Type: Short Survey

References (17)

1. R. J. Garten, C. T. Davis, C. A. Russell, B. Shu, S. Lindstrom, A. Balish, W. M. Sessions, X. Xu, E. Skepner, V. Deyde, M. Okomo-Adhiambo, L. Gubareva, J. Barnes, C. B. Smith, S. L. Emery, M. J. Hillman, P. Rivailler, J. Smagala, M. De Graaf, D. F. Burke, R. A. Fouchier, C. Pappas, C. M. Alpuche-Aranda, H. López-Gatell, H. Olivera, I. López, C. A. Myers, D. Faix, P. J. Blair, C. Yu, K. M. Keene, P. D. Dotson Jr., D. Boxrud, A. R. Sambol, S. H. Abid, K. St. George, T. Bannerman, A. L. Moore, D. J. Stringer, P. Blevins, G. J. Demmler-Harrison, M. Ginsberg, P. Kriner, S. Waterman, S. Smole, H. F. Guevara, E. A. Belongia, P. A. Clark, S. T. Beatrice, R. Donis, J. Katz, L. Finelli, C. B. Bridges, M. Shaw, D. B. Jernigan, T. M. Uyeki, D. J. Smith, A. I. Klimov, N. J. Cox, Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197-201 (2009).
2. T. W. Clark, M. Pareek, K. Hoschler, H. Dillon, K. G. Nicholson, N. Groth, I. Stephenson, Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361, 2424-2435 (2009).
3. C.-J. Wei, J. C. Boyington, K. Dai, K. V. Houser, M. B. Pearce, W.-p. Kong, Z.-y. Yang, T. M. Tumpey, G. J. Nabel, Crossneutralization of 1918 and 2009 influenza viruses: Role of glycans in viral evolution and vaccine design. Sci Transl. Med. 2, 24ra21 (2010).
4. R. Xu, D. C. Ekiert, J. C. Krause, R. Hai, J. E. Crowe, I. A. Wilson, Structural basis of pre-existing immunity to the 2009 H1N1 pandemic influenza virus. Science 24 March 2010 (10. 1126/science. 1186430).
5. M. Bröker, P. M. Dull, R. Rappuoli, P. Costantino, Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages. Vaccine 27, 5574-5580 (2009).
6. I. A. Wilson, J. J. Skehel, D. C. Wiley, Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289, 366-373 (1981).
7. I. H. Brown, S. Ludwig, C. W. Olsen, C. Hannoun, C. Scholtissek, V. S. Hinshaw, P. A. Harris, J. W. McCauley, I. Strong, D. J. Alexander, Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs. J. Gen. Virol. 78, 553-562 (1997).
8. A. J. Parodi, Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem. J. 348, 1-13 (2000).
9. Centers for Disease Control and Prevention (CDC), Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58, 521-524 (2009).
10. T. Lin, G. Wang, A. Li, Q. Zhang, C. Wu, R. Zhang, Q. Cai, W. Song, K. Y. Yuen, The hemagglutinin structure of an avian H1N1 influenza A virus. Virology 392, 73-81 (2009).
11. G. Galli, K. Hancock, K. Hoschler, J. DeVos, M. Praus, M. Bardelli, C. Malzone, F. Castellino, C. Gentile, T. McNally, G. Del Giudice, A. Banzhoff, V. Brauer, E. Montomoli, M. Zambon, J. Katz, K. Nicholson, I. Stephenson, Fast rise of broadly cross-reactive antibodies after boosting longlived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc. Natl. Acad. Sci. U. S. A. 106, 7962-7967 (2009).
12. D. C. Ekiert, G. Bhabha, M. A. Elsliger, R. H. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, I. A. Wilson, Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251 (2009).
13. J. Sui, W. C. Hwang, S. Perez, G. Wei, D. Aird, L. M. Chen, E. Santelli, B. Stec, G. Cadwell, M. Ali, H. Wan, A. Murakami, A. Yammanuru, T. Han, N. J. Cox, L. A. Bankston, R. O. Donis, R. C. Liddington, W. A. Marasco, Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273 (2009).
14. Y. Okuno, Y. Isegawa, F. Sasao, S. Ueda, A common neutralizing epitope conserved between the hemagglutinins hemag-glutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552-2558 (1993). http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?md=Retrieve&db=PubMed&list-uids=7682624&dopt=Abstract.
15. J. J. Skehel, D. C. Wiley, Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569 (2000).
16. E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
17. S. J. Gamblin, L. F. Haire, R. J. Russell, D. J. Stevens, B. Xiao, Y. Ha, N. Vasisht, D. A. Steinhauer, R. S. Daniels, A. Elliot, D. C. Wiley, J. J. Skehel, The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838-1842 (2004).